Maurizio Tassi has been a supporter of the IMSoGB for over 20 years. Maurizio is a banker and a investment manager with a special interest in the medical and pharmaceutical sector. During his time at Schroders and Citigroup he has been involved in the privatisation and floatation of Gedeon Richter in Hungary ,in the dual listing of Biomarin Pharmaceuticals in Switzerland and the U.S.A. and the IPO of Amplifon in Italy. He has been on the board of Lay Line Genomics, which was a spin off of Sissa and of Molmed , which was a spin off of Fondazione San Raffaele and is listed on the Milan stock exchange. Maurizio has a B.Sc. in Anthropology from UCL and an M.Sc. in Economics from the L.S.E.